Indeed, while most of the studies reported increased levels of active ghrelin in the plasma of patients with mood disorders and in stressed-based animal models of depression, exogenous ghrelin administration has been shown to exert antidepressant and anxiolytic effects. The gene discussed is GHRL; the disease is depressive disorder.